Vitamin E and diabetic nephropathy in mice model and humans

Figure 3 Kaplan-Meier plot. A: The composite end point in haptoglobin (Hp) 2-2 Hp diabetes mellitus (DM) individuals allocated to vitamin (Vit) E or Placebo. Events are cardiovascular death, myocardial infarction or stroke. There was a significant decrease in the composite end point in the vitamin E group compared with placebo group (P = 0.01 by Log-Rank); B: The composit end point in Hp 1-1 and Hp 2-1 DM individuals compared with Hp 2-2 DM individuals receiving vitamin E or placebo.